Search Results - Jean-Pascal Machiels
- Showing 1 - 8 results of 8
-
1
-
2
Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends by Hanna M. Peacock, Cindy De Gendt, Geert Silversmit, Sandra Nuyts, Sandra Nuyts, Jan Casselman, Jean-Pascal Machiels, Jean-Pascal Machiels, Francesco Giusti, Bart van Gool, Vincent Vander Poorten, Vincent Vander Poorten, Liesbet Van Eycken
Published in Frontiers in Oncology (2023-09-01)Get full text
Article -
3
Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer by Vassiliki Pasoglou, Sandy Van Nieuwenhove, Julien Van Damme, Nicolas Michoux, Aline Van Maanen, Laurence Annet, Jean-Pascal Machiels, Bertrand Tombal, Frederic E. Lecouvet
Published in Life (2022-01-01)Get full text
Article -
4
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the H... by Emmanuel Seront, Emmanuel Seront, Sandra Schmitz, Matthias Papier, Aline van Maanen, Stéphanie Henry, Christophe Lonchay, Sylvie Rottey, Gabrielle van Caloen, Jean-Pascal Machiels
Published in Frontiers in Oncology (2019-03-01)Get full text
Article -
5
433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04 by Bhumsuk Keam, Kevin Harrington, Ezra Cohen, Jean-Pascal Machiels, Feng Jin, Alison Forgie, Shanhong Guan, Jaume Pons, Beatriz Cirauqui, Sjoukje Oosting, Tim Welliver, Philip Fanning, Katherine Ruffner, Sophia Randolph
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
6
351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and... by Makoto Tahara, Kevin Harrington, Ezra Cohen, Barbara Burtness, Quynh-Thu Le, Lisa Licitra, Jean-Pascal Machiels, Lilian Siu, Danny Rischin, Jan Vermorken, Natalyn Hawk, Joy Ge, Behzad Bidadi, Ramona Swaby
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
7
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients by Jean-Marie Michot, Wolfgang Jacob, Francesca Michielin, Martin Weisser, Dmitriy Zamarin, Jean-Pascal Machiels, Anna-Maria Jegg, Dominik Rüttinger, Konstanty Korski, Jean-Pierre Delord, Carlos Gomez-Roca, Tara Mitchell, Gaetan Catala, Lauriane Eberst, Michael A Cannarile, Carl Watson, Galina Babitzki, Irina Klaman, Priscila Teixeira, Sabine Hoves, Carola Ries, Georgina Meneses-Lorente, Randolph Christen, Philippe Cassier
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
8
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma by Valentin Van den bossche, Julie Vignau, Engy Vigneron, Isabella Rizzi, Hannah Zaryouh, An Wouters, Jérôme Ambroise, Steven Van Laere, Simon Beyaert, Raphaël Helaers, Cédric van Marcke, Lionel Mignion, Elise Y. Lepicard, Bénédicte F. Jordan, Céline Guilbaud, Olivier Lowyck, Hajar Dahou, Antonella Mendola, Manon Desgres, Léo Aubert, Isabelle Gerin, Guido T. Bommer, Romain Boidot, Perrine Vermonden, Aurélien Warnant, Yvan Larondelle, Jean-Pascal Machiels, Olivier Feron, Sandra Schmitz, Cyril Corbet
Published in Nature Communications (2025-02-01)Get full text
Article
